Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
作者信息
Hawkes Nigel
机构信息
London.
出版信息
BMJ. 2014 Sep 1;349:g5382. doi: 10.1136/bmj.g5382.
PMID:25180006
Abstract
摘要
相似文献
1
Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
BMJ. 2014 Sep 1;349:g5382. doi: 10.1136/bmj.g5382.
2
Cancer drugs dropped from 'unsustainable' fund list.
Nurs Stand. 2015 Sep 23;30(4):10. doi: 10.7748/ns.30.4.10.s11.
3
Head of Cancer Drugs Fund regrets its establishment, conference hears.
BMJ. 2015 Jan 15;350:h270. doi: 10.1136/bmj.h270.
4
Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.
Br J Hosp Med (Lond). 2015 Apr;76(4):186-7. doi: 10.12968/hmed.2015.76.4.186.
5
Government's fund is improving access to drugs for patients with cancer.
BMJ. 2011 Dec 5;343:d7918. doi: 10.1136/bmj.d7918.
6
No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog.
BMJ. 2015 Sep 16;351:h4988. doi: 10.1136/bmj.h4988.
7
UK Cancer Drugs Fund to reassess 42 agents.
Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71137-4. Epub 2014 Nov 21.
8
NHS England pulls funding from 25 cancer treatments.
BMJ. 2015 Jan 13;350:h214. doi: 10.1136/bmj.h214.
9
NHS England drops 16 medicines from Cancer Drugs Fund.
BMJ. 2015 Sep 7;351:h4803. doi: 10.1136/bmj.h4803.
10
Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity.
N Z Med J. 2016 Aug 19;129(1440):22-4.
引用本文的文献
1
Regulation of the pharmaceutical industry: promoting health or protecting wealth?
J R Soc Med. 2015 Jun;108(6):220-2. doi: 10.1177/0141076814568299. Epub 2015 Apr 28.
Zotero 插件